We are live on ! Find out more
NUVB icon

Nuvation Bio

119 hedge funds and large institutions have $503M invested in Nuvation Bio in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 47 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

2% more funds holding

Funds holding: 117119 (+2)

1.51% less ownership

Funds ownership: 73.01%71.5% (-1.5%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

40% less capital invested

Capital invested by funds: $837M → $503M (-$334M)

43% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 47

Holders
119
Holders Change
+2
Holders Change %
+1.71%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
21
Increased
27
Reduced
47
Closed
17
Calls
Puts
Net Calls
Net Calls Change

NUVB Hedge Fund Activity: Q2 2022 in Review

119 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q2 2022, worth a combined $503M — down 40% from $837M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NUVB positions and 17 closed out — a net gain of 4 holders — while 27 added to existing stakes and 47 trimmed.

The largest buyer was Deep Track Capital, adding an estimated $45M. The largest seller was Omega Fund Management, cutting an estimated $33.6M.

  • 119 institutional investors held Nuvation Bio (NUVB) as of Q2 2022, up from 117 in Q1 2022.
  • Funds reported $503M of Nuvation Bio stock for Q2 2022, down 40% quarter-over-quarter.
  • 21 funds opened new Nuvation Bio positions in Q2 2022 and 17 closed out, a net change of +4 holders.
  • The largest Nuvation Bio buyer in Q2 2022 was Deep Track Capital, an estimated $45M added.
  • The largest Nuvation Bio seller in Q2 2022 was Omega Fund Management, an estimated $33.6M sold.

Based on aggregated 13F filings for Q2 2022.